NCT06105346

Brief Summary

The aim of the present study will be to evaluate in conscripts at the military induction board the prevalence of rhinosinusitis, the prevalence of HPV vaccinations, the prevalence of hearing impairments and the prevalence of long-COVID symptoms and further, to evaluate different factors that influence on the one hand the prevalence (urban-bred, non-urban-bred) and on the other hand symptoms (ENT-surgeries in medical history). Further, we want to evaluate if there is a correlation between subjective symptoms and apparated-based diagnostic investigations. Therefore, questionnaires and data of medical examinations, aquired routinely at the military induction board, will be analysed.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2023

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 27, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

October 27, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

October 9, 2023

Last Update Submit

October 23, 2023

Conditions

ConscriptsMilitary Induction BoardENT DiseaseRhinosinusitis ChronicRhinosinusitisHPV InfectionHPV VaccineLong COVIDENT Surgery

Keywords

ENTprevalencemilitary induction boardconscriptsrhinosinusitisLong COVIDENT surgeriesHPV vaccinationinborn hearing loss

Outcome Measures

Primary Outcomes (4)

  • Prevalence of rhinosinusitis

    To assess whether there is a difference in prevalence of rhinosinusitis in urban-bred conscripts compared to non-urban-bred conscripts.

    Through data collection, an average of 1 week

  • Prevalence of human papilloma virus vaccination

    To assess whether there is a difference in prevalence of human papilloma virus vaccinations in urban-bred conscripts compared to non-urban-bred conscripts.

    Through data collection, an average of 1 week

  • Prevalence of hearing impairment

    To assess whether there is a difference in prevalence of hearing impairment in urban-bred conscripts compared to non-urban-bred conscripts.

    Through data collection, an average of 1 week

  • Prevalence of long-COVID disease

    To assess whether there is a difference in prevalence of long-COVID disease in vaccinated conscripts compared to no-vaccinated conscripts.

    Through data collection, an average of 1 week

Secondary Outcomes (16)

  • Prevalence of rhinosinusitis

    Through data collection, an average of 1 week

  • Prevalence of rhinosinusitis

    Through data collection, an average of 1 week

  • Prevalence of rhinosinusitis

    Through data collection, an average of 1 week

  • Prevalence of rhinosinusitis

    Through data collection, an average of 1 week

  • Prevalence of rhinosinusitis

    Through data collection, an average of 1 week

  • +11 more secondary outcomes

Eligibility Criteria

Age17 Years - 19 Years
Sexmale(Gender-based eligibility)
Gender Eligibility Detailsonly Austrian males (conscripts), who are invited at the military induction board
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

All male Austrian conscripts who take part at the military inductions board are eligible for the study inclusion.

You may qualify if:

  • participation of the military induction board of conscripts
  • consent for participation obtained by the conscripts
  • completed questionnaire (with at least 50% completeness of each subcategory)
  • participation of medical examination

You may not qualify if:

  • no consent for participation in the study by the conscripts
  • incomplete questionnaire (with less than 50% completeness of each subcategory)
  • no participation of medical examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Otorhinolaryngologic DiseasesRhinosinusitisPapillomavirus InfectionsPost-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

RhinitisRespiratory Tract InfectionsInfectionsSinusitisParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesCommunicable DiseasesDNA Virus InfectionsVirus DiseasesTumor Virus InfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsCOVID-19Pneumonia, ViralPneumoniaCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesPost-Infectious DisordersChronic Disease

Central Study Contacts

Emanuel Maitz, MD

CONTACT

00436604756105emanuel.maitz@medunigraz.at

Reinhard Domanyi, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Week
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2023

First Posted

October 27, 2023

Study Start

December 1, 2023

Primary Completion

December 1, 2025

Study Completion

March 31, 2026

Last Updated

October 27, 2023

Record last verified: 2023-10